Clinical Trials Directory

Trials / Conditions / Neoplasm, Breast

Neoplasm, Breast

14 registered clinical trials studyying Neoplasm, Breast — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingTRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast C
NCT06251544
Baylor College of MedicinePhase 1
RecruitingSacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINST
NCT05465031
Silesian Centre for Heart DiseasesPhase 4
RecruitingTCM Therapy Program Impact on Breast Cancer Patients' Vital Energy
NCT06337214
Taipei City HospitalN/A
WithdrawnDevelopment, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs
NCT05512260
Karolinska InstitutetN/A
UnknownIdentifying Biomarkers for Chronic Pain After Breast Cancer Treatment.
NCT05507034
Universiteit Antwerpen—
RecruitingBreast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
NCT05851053
University Medical Center Groningen—
Active Not RecruitingSEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)
NCT05392608
Borstkanker Onderzoek GroepPhase 2
UnknownAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer
NCT05033769
Institut fuer FrauengesundheitPhase 4
RecruitingAxillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Che
NCT04109079
University Hospitals of Derby and Burton NHS Foundation TrustN/A
CompletedCooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients
NCT04678544
Samsung Medical CenterN/A
UnknownNeoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
NCT03756064
Zhejiang Cancer HospitalN/A
Active Not Recruiting9-ING-41 in Patients With Advanced Cancers
NCT03678883
Actuate Therapeutics Inc.Phase 2
UnknownTo Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes
NCT03715686
Peking UniversityN/A
CompletedDS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Prote
NCT03368196
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo CompanyPhase 1